In this post, I argue for a new minimum transparency criterion for developing successful analytics science methods and algorithms that are aimed at having a positive public impact: making sure that they do...
Soroush_SaghafHonored to be recognized by the 2021 @INFORMS#MSOM Society Young Scholar Prize. Not sure I deserve to be called scholar or young. Grateful to all the mentees & mentors who made me a better researcher & to this book who has taught me a lot a/b a true scholar. @Kennedy_Schoolt.co/EQn6mKJOqS
Soroush_SaghafACIP made 2 mistakes: pausing & extending. I’ve been w @NateSilver538 on this. Any cost-benefit analysis shows the need to get people vaccinated. Cases w thrombocytopenia:J&J: 8 (all US), AZ: 287, Pfizer: 25, Moderna: 5. #ACIP should have had people w better #analytics background t.co/WrOlIVkcWq
Soroush_SaghafAll the calculations I’ve seen so far miss serious risk adjustments. High risk women were prioritized for vaccination. Their risk profile is <> who will be vaccinated later. Stratification using age seems insufficient. My hope: Final recommendation goes beyond age. @ashishkjhat.co/bizW2escKp
Soroush_SaghafA massive change of strategy: vaccines in MA are suddenly diverted from hospitals to state-run vaccination clinics. When there is no advance planning/study of how to effectively distribute, states end up changing their plans as they go. t.co/CCYq86qEpO via @commonhealth
Soroush_SaghafGreat news a/b the J&J #vaccine@Harvard Gazette"[it] now has proven efficacy against not just the virus that has been circulating, but also the new variants that are partially resistant and are already present in the US and are dominant viruses elsewhere" t.co/5aEV8ziYBb